Skip to main content

Brittany A Davidson

Associate Professor of Obstetrics and Gynecology
Obstetrics and Gynecology, Gynecologic Oncology
Box 3079 Duke Medical Center, Durham, NC 27710
25172 Morris Building, Box 3079 Duke Medical Center, Durham, NC 27710

Overview


My research passion lies at the intersection of gynecologic cancers and palliative care, helping patients with GYN cancers and their families navigate the journey of their cancer diagnoses to maximize their quality of life and mitigate aggressive and futile care near the end of life. I am also passionate about how the healthcare team communicates with patients and their families. Cancer care should be patient-centered based on an individual's own values--this requires comprehensive goals of care conversations early and often throughout the cancer trajectory. This has led me to become involved in VitalTalk Communication Skills training, which I have taught both locally at Duke and across the country to clinicians in various clinical settings. 

Clinically, caring for patients with gestational trophoblastic neoplasms and cancers in adolescents and young adults is a rewarding aspect of my job. Helping patients and their families navigate cancer diagnoses and the potential impact this has on growing families is rewarding. I enjoy working in a multi-disciplinary approach with our reproductive endocrinology, psychology, and cancer support teams to maximize longevity, quality of life and family building opportunities. 

As the program director for the OB/GYN department, medical education and simulation is also near and dear to my heart. I find great joy in mentoring trainees at all stages and in all venues--clinically, research, and professionally.

Current Duke Appointments & Affiliations


Associate Professor of Obstetrics and Gynecology · 2022 - Present Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology
Associate Program Director of the Duke Ob/Gyn Residency Program · 2019 - Present Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology
Member of the Duke Cancer Institute · 2017 - Present Duke Cancer Institute, Institutes and Centers

Recent News Items


Published November 8, 2022
Reigniting the White House Cancer Moonshot in Gynecologic & Breast Cancers
Published June 1, 2021
ASCO Post
Brittany A. Davidson, MD, on a Model to Predict the Need for Opioids After Gynecologic Surgery

View All News Items

Recent Scholarly Works


Contraceptive practices during monitoring for molar pregnancy: A mixed methods analysis.

Journal article Contraception · July 14, 2026 OBJECTIVE: To describe patterns in contraceptive use and factors influencing contraceptive decision-making during the post-molar beta-hCG monitoring period. STUDY DESIGN: This was a mixed methods analysis of patients who received care for molar pregnancy a ... Full text Link to item Cite

Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN study.

Journal article Gynecol Oncol · July 2026 OBJECTIVE: Evaluate safety, efficacy, and response markers to atezolizumab, an immune checkpoint inhibitor, when combined with neoadjuvant chemotherapy (NACT) for primary epithelial ovarian, tubal, and peritoneal cancer (EOC). METHODS: Eligible patients ha ... Full text Link to item Cite

A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.

Journal article Int J Gynecol Cancer · June 2026 OBJECTIVE: Weekly dose-dense paclitaxel may have immunomodulatory effects, enhancing immune responses via cytotoxic T-cell infiltration. Therefore, we assessed the combination of weekly dose-dense paclitaxel with pembrolizumab in patients with platinum-res ... Full text Link to item Cite
View All Scholarly Works

Education


University of Virginia · 2009 M.D.